We are live on ! Find out more
VOYA Investment Management

VOYA Investment Management Portfolio holdings

AUM $116B
1-Year Est. Return 61.47%
This Fund
S&P 500
This Quarter Est. Return
-14.67%
1 Year Est. Return
+61.47%
3 Year Est. Return
+172.42%
5 Year Est. Return
+231.94%
10 Year Est. Return
+892.64%
AUM
$39.6B
AUM Growth
-$8.6B
Cap. Flow
-$515M
Cap. Flow %
-1.3%
Top 10 Hldgs %
21.58%
Holding
2,991
New
339
Increased
842
Reduced
1,284
Closed
225

Top Sells

Rank Stock Value
1
ZBRA icon
Zebra Technologies
ZBRA
+$196M
2
ORLY icon
O'Reilly Automotive
ORLY
+$193M
3
ROST icon
Ross Stores
ROST
+$180M
4
LLY icon
Eli Lilly
LLY
+$164M
5
CDW icon
CDW
CDW
+$153M

Sector Composition

Rank Sector Weight
1 Technology 24.12%
2 Healthcare 14.61%
3 Financials 10.79%
4 Consumer Discretionary 10.65%
5 Industrials 9.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FUV
2926
DELISTED
Arcimoto, Inc. Common Stock
FUV
-527
Closed -$70K
CBAY
2927
DELISTED
Cymabay Therapeutics
CBAY
-29,653
Closed -$92K
BCEL
2928
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
-10,117
Closed -$32K
BFX
2929
DELISTED
BowFlex Inc.
BFX
-12,986
Closed -$54K
ONCT
2930
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
-799
Closed -$22K
CD
2931
DELISTED
Chindata Group Holdings Limited American Depositary Shares
CD
-13,544
Closed -$86K
LTRPA
2932
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
-29,832
Closed -$61K
HCCI
2933
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
-7,055
Closed -$209K
PRTK
2934
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
-21,295
Closed -$63K
INFI
2935
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
-193,083
Closed -$220K
IDEX
2936
DELISTED
Ideanomics, Inc. Common Stock
IDEX
-1,382
Closed -$193K
MTEM
2937
DELISTED
Molecular Templates, Inc.
MTEM
-1,263
Closed -$65K
SPPI
2938
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
-60,328
Closed -$78K
HGEN
2939
DELISTED
HUMANIGEN, INC.
HGEN
-16,523
Closed -$50K
NMTR
2940
DELISTED
9 Meters Biopharma
NMTR
-4,016
Closed -$48K
USX
2941
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
-12,468
Closed -$48K
EVLO
2942
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
-600
Closed -$41K
TCRR
2943
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
-11,040
Closed -$30K
TA
2944
DELISTED
TravelCenters of America LLC
TA
-5,184
Closed -$223K
SFT
2945
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
-2,162
Closed -$48K
RUBY
2946
DELISTED
Rubius Therapeutics, Inc
RUBY
-18,095
Closed -$100K
ALBO
2947
DELISTED
Albireo Pharma Inc
ALBO
-6,772
Closed -$202K
ATNX
2948
DELISTED
Athenex, Inc. Common Stock
ATNX
-1,510
Closed -$25K
IVC
2949
DELISTED
Invacare Corporation
IVC
-11,688
Closed -$16K
DS
2950
DELISTED
Drive Shack Inc.
DS
-29,405
Closed -$45K

Similar funds

VOYA Investment Management's Q2 2022 Portfolio in Review

As of Q2 2022, VOYA Investment Management held 2,991 positions worth $39.6B, down 18% from $48.2B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

VOYA Investment Management's Q2 2022 filing shows 339 new, 842 increased, 1,284 reduced and 225 closed positions. Its largest new stake was iShares MSCI Japan ETF: 5,498,157 shares worth $290M. The largest sale was Zebra Technologies, an estimated $196M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.

  • VOYA Investment Management's largest Q2 2022 buy was iShares MSCI Japan ETF: 5,498,157 shares worth $290M.
  • VOYA Investment Management added most to Visa in Q2 2022, an estimated $356M increase.
  • VOYA Investment Management's biggest Q2 2022 reduction was Zebra Technologies, cutting an estimated $196M.
  • VOYA Investment Management fully exited Canada Goose Holdings in Q2 2022, selling an estimated $11M.
  • VOYA Investment Management's ten largest holdings make up 22% of its $39.6B portfolio in Q2 2022.
  • VOYA Investment Management opened 339 new positions and closed 225 in Q2 2022.
  • VOYA Investment Management's portfolio value fell 18% quarter-over-quarter to $39.6B.

Based on VOYA Investment Management's 13F filing for Q2 2022, filed 15 Aug 2022.